Vor Biopharma's total assets for Q3 2024 were $115.99M, a decrease of -18.08% from the previous quarter. VOR total liabilities were $43.04M for the fiscal quarter, a -1.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.